| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | 6.11e-05 | 430 | 47 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.81e-05 | 188 | 47 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.81e-04 | 120 | 47 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | Roundabout binding | 3.53e-04 | 12 | 47 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | peptidase activity | 7.88e-04 | 654 | 47 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.24e-03 | 200 | 47 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.11e-03 | 29 | 47 | 2 | GO:0043395 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 1.23e-06 | 10 | 46 | 3 | GO:1990705 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.71e-06 | 14 | 46 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.46e-05 | 3 | 46 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | negative regulation of cholangiocyte proliferation | 1.46e-05 | 3 | 46 | 2 | GO:1904055 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 1.55e-05 | 22 | 46 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 1.55e-05 | 22 | 46 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.78e-05 | 23 | 46 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 2.91e-05 | 4 | 46 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | axon guidance | 3.89e-05 | 285 | 46 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.96e-05 | 286 | 46 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 4.66e-05 | 178 | 46 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 4.85e-05 | 5 | 46 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 8.29e-05 | 38 | 46 | 3 | GO:0030517 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 1.35e-04 | 8 | 46 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.47e-04 | 46 | 46 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.47e-04 | 46 | 46 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.67e-04 | 124 | 46 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.78e-04 | 49 | 46 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 2.16e-04 | 10 | 46 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 2.38e-04 | 54 | 46 | 3 | GO:0050922 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.39e-04 | 566 | 46 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension involved in axon guidance | 2.64e-04 | 11 | 46 | 2 | GO:0048843 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 2.64e-04 | 11 | 46 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 3.37e-04 | 149 | 46 | 4 | GO:0010811 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 3.58e-04 | 62 | 46 | 3 | GO:0050771 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 3.74e-04 | 13 | 46 | 2 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 3.74e-04 | 13 | 46 | 2 | GO:0021843 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | LAMA5 SLIT2 CSRNP1 ABLIM1 LIMS1 WNT3 NOTCH2 CFTR SLIT1 LIMS2 | 3.99e-04 | 1269 | 46 | 10 | GO:0009887 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 4.63e-04 | 162 | 46 | 4 | GO:0072073 | |
| GeneOntologyBiologicalProcess | axon development | 5.10e-04 | 642 | 46 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 6.48e-04 | 17 | 46 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 7.28e-04 | 18 | 46 | 2 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 8.12e-04 | 19 | 46 | 2 | GO:1904321 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 9.01e-04 | 20 | 46 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 9.01e-04 | 20 | 46 | 2 | GO:2000346 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.25e-03 | 748 | 46 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 1.30e-03 | 24 | 46 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 1.30e-03 | 24 | 46 | 2 | GO:0031290 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMA5 ADAMTS20 SLIT2 FBLN2 BMPER FCGBP ADAMTS2 SSPOP WNT3 F12 OTOG | 1.67e-07 | 656 | 47 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMA5 ADAMTS20 SLIT2 FBLN2 BMPER FCGBP ADAMTS2 SSPOP WNT3 F12 OTOG | 1.72e-07 | 658 | 47 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.13e-05 | 530 | 47 | 8 | GO:0062023 | |
| HumanPheno | Widely spaced toes | 2.77e-05 | 3 | 16 | 2 | HP:0008094 | |
| Domain | EGF-like_dom | TENM1 PCSK5 LAMA5 SLIT2 FBLN2 FCGBP LRP1B ADAM21 VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 OTOG | 2.52e-17 | 249 | 47 | 15 | IPR000742 |
| Domain | EGF_3 | TENM1 SLIT2 FBLN2 SSPOP LRP1B ADAM21 VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 OTOG | 1.37e-14 | 235 | 47 | 13 | PS50026 |
| Domain | EGF | TENM1 PCSK5 LAMA5 SLIT2 FBLN2 FCGBP LRP1B VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 | 1.37e-14 | 235 | 47 | 13 | SM00181 |
| Domain | EGF_1 | TENM1 LAMA5 SLIT2 FBLN2 SSPOP LRP1B ADAM21 VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 | 3.93e-14 | 255 | 47 | 13 | PS00022 |
| Domain | EGF_2 | TENM1 LAMA5 SLIT2 FBLN2 SSPOP LRP1B ADAM21 VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 | 6.44e-14 | 265 | 47 | 13 | PS01186 |
| Domain | EGF-like_CS | TENM1 LAMA5 SLIT2 FBLN2 LRP1B ADAM21 VWDE ADAM28 F12 MEGF10 NOTCH2 SLIT1 | 1.46e-12 | 261 | 47 | 12 | IPR013032 |
| Domain | VWD | 3.47e-10 | 16 | 47 | 5 | SM00216 | |
| Domain | VWF_type-D | 3.47e-10 | 16 | 47 | 5 | IPR001846 | |
| Domain | VWFD | 3.47e-10 | 16 | 47 | 5 | PS51233 | |
| Domain | VWD | 3.47e-10 | 16 | 47 | 5 | PF00094 | |
| Domain | TIL | 1.72e-08 | 12 | 47 | 4 | PF01826 | |
| Domain | C8 | 1.72e-08 | 12 | 47 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.47e-08 | 13 | 47 | 4 | IPR014853 | |
| Domain | C8 | 2.47e-08 | 13 | 47 | 4 | SM00832 | |
| Domain | TIL_dom | 3.46e-08 | 14 | 47 | 4 | IPR002919 | |
| Domain | Cys_knot_C | 4.28e-07 | 25 | 47 | 4 | IPR006207 | |
| Domain | CTCK_2 | 4.28e-07 | 25 | 47 | 4 | PS01225 | |
| Domain | EGF_CA | 5.92e-07 | 122 | 47 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.52e-07 | 124 | 47 | 6 | IPR001881 | |
| Domain | hEGF | 6.89e-07 | 28 | 47 | 4 | PF12661 | |
| Domain | Fol_N | 2.43e-06 | 11 | 47 | 3 | IPR003645 | |
| Domain | FOLN | 2.43e-06 | 11 | 47 | 3 | SM00274 | |
| Domain | Growth_fac_rcpt_ | 2.50e-06 | 156 | 47 | 6 | IPR009030 | |
| Domain | Peptidase_M12B_N | 2.71e-06 | 39 | 47 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.71e-06 | 39 | 47 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.01e-06 | 40 | 47 | 4 | PS00427 | |
| Domain | Reprolysin | 3.01e-06 | 40 | 47 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 3.01e-06 | 40 | 47 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.01e-06 | 40 | 47 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 3.01e-06 | 40 | 47 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.33e-06 | 41 | 47 | 4 | IPR001762 | |
| Domain | VWF_dom | 3.67e-06 | 42 | 47 | 4 | IPR001007 | |
| Domain | EGF_Ca-bd_CS | 4.39e-06 | 97 | 47 | 5 | IPR018097 | |
| Domain | EGF_CA | 4.86e-06 | 99 | 47 | 5 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.80e-06 | 106 | 47 | 5 | IPR000152 | |
| Domain | CTCK_1 | 1.19e-05 | 18 | 47 | 3 | PS01185 | |
| Domain | VWC_out | 1.41e-05 | 19 | 47 | 3 | SM00215 | |
| Domain | EGF | 1.58e-05 | 126 | 47 | 5 | PF00008 | |
| Domain | ZnF_NFX | 1.86e-05 | 3 | 47 | 2 | SM00438 | |
| Domain | zf-NF-X1 | 1.86e-05 | 3 | 47 | 2 | PF01422 | |
| Domain | Znf_NFX1 | 1.86e-05 | 3 | 47 | 2 | IPR000967 | |
| Domain | PINCH | 1.86e-05 | 3 | 47 | 2 | IPR017351 | |
| Domain | CT | 2.22e-05 | 22 | 47 | 3 | SM00041 | |
| Domain | MetalloPept_cat_dom | 5.08e-05 | 81 | 47 | 4 | IPR024079 | |
| Domain | - | 5.08e-05 | 81 | 47 | 4 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.07e-04 | 98 | 47 | 4 | PS00142 | |
| Domain | ASX_HYDROXYL | 1.16e-04 | 100 | 47 | 4 | PS00010 | |
| Domain | VWC | 1.18e-04 | 38 | 47 | 3 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.18e-04 | 38 | 47 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.38e-04 | 40 | 47 | 3 | PF02210 | |
| Domain | LamG | 1.84e-04 | 44 | 47 | 3 | SM00282 | |
| Domain | Laminin_G | 4.18e-04 | 58 | 47 | 3 | IPR001791 | |
| Domain | EGF_extracell | 4.62e-04 | 60 | 47 | 3 | IPR013111 | |
| Domain | EGF_2 | 4.62e-04 | 60 | 47 | 3 | PF07974 | |
| Domain | TSP_1 | 5.34e-04 | 63 | 47 | 3 | PF00090 | |
| Domain | TSP1 | 5.85e-04 | 65 | 47 | 3 | SM00209 | |
| Domain | TSP1_rpt | 5.85e-04 | 65 | 47 | 3 | IPR000884 | |
| Domain | TSP1 | 5.85e-04 | 65 | 47 | 3 | PS50092 | |
| Domain | LIM | 6.97e-04 | 69 | 47 | 3 | PF00412 | |
| Domain | - | 7.26e-04 | 70 | 47 | 3 | 2.10.110.10 | |
| Domain | Disintegrin_CS | 7.27e-04 | 16 | 47 | 2 | IPR018358 | |
| Domain | Znf_LIM | 7.57e-04 | 71 | 47 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 7.57e-04 | 71 | 47 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 7.57e-04 | 71 | 47 | 3 | PS50023 | |
| Domain | LIM | 7.57e-04 | 71 | 47 | 3 | SM00132 | |
| Domain | EMI | 8.23e-04 | 17 | 47 | 2 | PS51041 | |
| Domain | ADAM_CR | 9.24e-04 | 18 | 47 | 2 | PF08516 | |
| Domain | PLAC | 1.03e-03 | 19 | 47 | 2 | PS50900 | |
| Domain | PLAC | 1.03e-03 | 19 | 47 | 2 | IPR010909 | |
| Domain | - | 1.14e-03 | 20 | 47 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 1.26e-03 | 21 | 47 | 2 | PF00200 | |
| Domain | DISIN | 1.26e-03 | 21 | 47 | 2 | SM00050 | |
| Domain | EGF_CA | 1.32e-03 | 86 | 47 | 3 | PF07645 | |
| Domain | ADAM_spacer1 | 1.52e-03 | 23 | 47 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.52e-03 | 23 | 47 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.65e-03 | 24 | 47 | 2 | IPR013273 | |
| Domain | Galactose-bd-like | 1.71e-03 | 94 | 47 | 3 | IPR008979 | |
| Domain | - | 1.76e-03 | 95 | 47 | 3 | 2.60.120.200 | |
| Domain | cEGF | 1.94e-03 | 26 | 47 | 2 | IPR026823 | |
| Domain | cEGF | 1.94e-03 | 26 | 47 | 2 | PF12662 | |
| Domain | ACR | 2.09e-03 | 27 | 47 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.09e-03 | 27 | 47 | 2 | IPR006586 | |
| Domain | LRRCT | 2.93e-03 | 32 | 47 | 2 | PF01463 | |
| Domain | Laminin_EGF | 3.50e-03 | 35 | 47 | 2 | PF00053 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.41e-05 | 68 | 31 | 4 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.34e-05 | 39 | 31 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.34e-05 | 39 | 31 | 3 | MM15165 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.20e-04 | 44 | 31 | 3 | M875 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 2.08e-04 | 10 | 31 | 2 | M27348 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.08e-04 | 10 | 31 | 2 | MM1377 | |
| Pathway | BIOCARTA_CFTR_PATHWAY | 2.54e-04 | 11 | 31 | 2 | M12399 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.58e-04 | 143 | 31 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.60e-04 | 13 | 31 | 2 | M47534 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 7.01e-04 | 18 | 31 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 7.01e-04 | 18 | 31 | 2 | M840 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.10e-07 | 358 | 47 | 7 | 32460013 | |
| Pubmed | Signaling via PINCH: Functions, binding partners and implications in human diseases. | 1.79e-06 | 2 | 47 | 2 | 27590440 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12515855 | ||
| Pubmed | Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice. | 1.79e-06 | 2 | 47 | 2 | 31723057 | |
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 1.79e-06 | 2 | 47 | 2 | 12200164 | |
| Pubmed | LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice. | 1.79e-06 | 2 | 47 | 2 | 33083097 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 33529444 | ||
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 1.79e-06 | 2 | 47 | 2 | 10432110 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 1.79e-06 | 2 | 47 | 2 | 12097499 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30530780 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20554763 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 36385586 | ||
| Pubmed | Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. | 1.79e-06 | 2 | 47 | 2 | 24058607 | |
| Pubmed | 2.21e-06 | 19 | 47 | 3 | 25691540 | ||
| Pubmed | 3.32e-06 | 75 | 47 | 4 | 20637190 | ||
| Pubmed | 4.02e-06 | 23 | 47 | 3 | 30470893 | ||
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 5.36e-06 | 3 | 47 | 2 | 16162649 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12167643 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 9813312 | ||
| Pubmed | A molecular mechanism for the heparan sulfate dependence of slit-robo signaling. | 5.36e-06 | 3 | 47 | 2 | 17062560 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 5.36e-06 | 3 | 47 | 2 | 12141424 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16840550 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28707394 | ||
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 5.36e-06 | 3 | 47 | 2 | 9006922 | |
| Pubmed | Brief research report: Effects of Pinch deficiency on cartilage homeostasis in adult mice. | 5.36e-06 | 3 | 47 | 2 | 36743414 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16317048 | ||
| Pubmed | New neurons follow the flow of cerebrospinal fluid in the adult brain. | 5.36e-06 | 3 | 47 | 2 | 16410488 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 10364234 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 5.36e-06 | 3 | 47 | 2 | 24065825 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 6.61e-06 | 27 | 47 | 3 | 24741061 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 9.73e-06 | 560 | 47 | 7 | 21653829 | |
| Pubmed | Multiple roles for slits in the control of cell migration in the rostral migratory stream. | 1.07e-05 | 4 | 47 | 2 | 14960623 | |
| Pubmed | Contralateral migration of oculomotor neurons is regulated by Slit/Robo signaling. | 1.07e-05 | 4 | 47 | 2 | 27770832 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 1.07e-05 | 4 | 47 | 2 | 16828733 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 11331308 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 10433822 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 12609596 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 1.78e-05 | 5 | 47 | 2 | 12954717 | |
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 1.78e-05 | 5 | 47 | 2 | 15207848 | |
| Pubmed | Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. | 1.78e-05 | 5 | 47 | 2 | 25894826 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 28234971 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 11520671 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 22000108 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 16885222 | ||
| Pubmed | Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals. | 1.78e-05 | 5 | 47 | 2 | 21118670 | |
| Pubmed | Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain. | 1.78e-05 | 5 | 47 | 2 | 24719101 | |
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 1.78e-05 | 5 | 47 | 2 | 11748139 | |
| Pubmed | Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. | 1.89e-05 | 38 | 47 | 3 | 31624071 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.13e-05 | 248 | 47 | 5 | 24006456 | |
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 2.67e-05 | 6 | 47 | 2 | 18829537 | |
| Pubmed | PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. | 2.67e-05 | 6 | 47 | 2 | 12651156 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 10864954 | ||
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 2.67e-05 | 6 | 47 | 2 | 22306607 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 2.67e-05 | 6 | 47 | 2 | 23161783 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 11804570 | ||
| Pubmed | Slit antagonizes netrin-1 attractive effects during the migration of inferior olivary neurons. | 2.67e-05 | 6 | 47 | 2 | 12051827 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 18054781 | ||
| Pubmed | Robo1 and robo2 control the development of the lateral olfactory tract. | 2.67e-05 | 6 | 47 | 2 | 17360927 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 2.67e-05 | 6 | 47 | 2 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 2.67e-05 | 6 | 47 | 2 | 34249921 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 28676569 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 21688288 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 3.74e-05 | 7 | 47 | 2 | 25490618 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 20606719 | ||
| Pubmed | A cascade of morphogenic signaling initiated by the meninges controls corpus callosum formation. | 4.34e-05 | 50 | 47 | 3 | 22365545 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 23884932 | ||
| Pubmed | Robos and slits control the pathfinding and targeting of mouse olfactory sensory axons. | 4.98e-05 | 8 | 47 | 2 | 18417704 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 4.98e-05 | 8 | 47 | 2 | 15091338 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 15162513 | ||
| Pubmed | Motor axons are guided to exit points in the spinal cord by Slit and Netrin signals. | 4.98e-05 | 8 | 47 | 2 | 28986144 | |
| Pubmed | Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain. | 4.98e-05 | 8 | 47 | 2 | 17392456 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 23658024 | ||
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 4.98e-05 | 8 | 47 | 2 | 22349628 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 4.98e-05 | 8 | 47 | 2 | 25485759 | |
| Pubmed | Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. | 4.98e-05 | 8 | 47 | 2 | 22912413 | |
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 10864955 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 25056828 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 22806432 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 6.40e-05 | 9 | 47 | 2 | 20631173 | |
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 21307234 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 12642493 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 31356769 | ||
| Pubmed | 9.09e-05 | 64 | 47 | 3 | 22261194 | ||
| Pubmed | 9.33e-05 | 175 | 47 | 4 | 28071719 | ||
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 9.75e-05 | 11 | 47 | 2 | 33347679 | |
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 9.75e-05 | 11 | 47 | 2 | 18562598 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 11804571 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 22399681 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 17903301 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 26520399 | ||
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 1.17e-04 | 12 | 47 | 2 | 23328398 | |
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 16540508 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 11830575 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 22981605 | ||
| Pubmed | Robo2 is required for Slit-mediated intraretinal axon guidance. | 1.17e-04 | 12 | 47 | 2 | 19782674 | |
| Pubmed | Sim1 and Sim2 are required for the correct targeting of mammillary body axons. | 1.17e-04 | 12 | 47 | 2 | 16291793 | |
| Pubmed | Dual role for LIM-homeodomain gene Lhx2 in the formation of the lateral olfactory tract. | 1.17e-04 | 12 | 47 | 2 | 17329426 | |
| Interaction | IGFL3 interactions | 2.06e-08 | 75 | 47 | 6 | int:IGFL3 | |
| Interaction | RNASE4 interactions | 4.25e-06 | 14 | 47 | 3 | int:RNASE4 | |
| Interaction | LYPD1 interactions | 1.00e-05 | 58 | 47 | 4 | int:LYPD1 | |
| Interaction | FBLN2 interactions | 1.68e-05 | 66 | 47 | 4 | int:FBLN2 | |
| Interaction | SLURP1 interactions | 2.09e-05 | 144 | 47 | 5 | int:SLURP1 | |
| Interaction | NTN5 interactions | 2.32e-05 | 24 | 47 | 3 | int:NTN5 | |
| Interaction | ZNF263 interactions | 2.47e-05 | 149 | 47 | 5 | int:ZNF263 | |
| Interaction | CST9L interactions | 3.26e-05 | 78 | 47 | 4 | int:CST9L | |
| Interaction | PRG2 interactions | 5.01e-05 | 285 | 47 | 6 | int:PRG2 | |
| Interaction | MSTN interactions | 6.18e-05 | 33 | 47 | 3 | int:MSTN | |
| Interaction | RLN1 interactions | 6.51e-05 | 93 | 47 | 4 | int:RLN1 | |
| Interaction | ATN1 interactions | 7.29e-05 | 187 | 47 | 5 | int:ATN1 | |
| Interaction | ADAMTS9 interactions | 7.94e-05 | 6 | 47 | 2 | int:ADAMTS9 | |
| Interaction | ZNF594 interactions | 1.11e-04 | 7 | 47 | 2 | int:ZNF594 | |
| Interaction | DEFB135 interactions | 1.28e-04 | 42 | 47 | 3 | int:DEFB135 | |
| Interaction | CCN1 interactions | 1.28e-04 | 42 | 47 | 3 | int:CCN1 | |
| Interaction | DEFB136 interactions | 1.47e-04 | 44 | 47 | 3 | int:DEFB136 | |
| Interaction | BMPER interactions | 1.48e-04 | 8 | 47 | 2 | int:BMPER | |
| Interaction | HOXA1 interactions | 1.70e-04 | 356 | 47 | 6 | int:HOXA1 | |
| Interaction | MYH13 interactions | 1.91e-04 | 48 | 47 | 3 | int:MYH13 | |
| Interaction | PRG3 interactions | 2.03e-04 | 49 | 47 | 3 | int:PRG3 | |
| Interaction | ZDHHC15 interactions | 2.05e-04 | 125 | 47 | 4 | int:ZDHHC15 | |
| Interaction | CFC1 interactions | 2.11e-04 | 126 | 47 | 4 | int:CFC1 | |
| Interaction | FBN1 interactions | 2.29e-04 | 51 | 47 | 3 | int:FBN1 | |
| Interaction | MKRN2 interactions | 2.59e-04 | 385 | 47 | 6 | int:MKRN2 | |
| Interaction | GPIHBP1 interactions | 2.60e-04 | 133 | 47 | 4 | int:GPIHBP1 | |
| Interaction | ZNF574 interactions | 2.63e-04 | 246 | 47 | 5 | int:ZNF574 | |
| Interaction | PCMT1 interactions | 3.16e-04 | 256 | 47 | 5 | int:PCMT1 | |
| Cytoband | 5q33 | 1.53e-05 | 6 | 47 | 2 | 5q33 | |
| Cytoband | 7p14.3 | 7.04e-04 | 38 | 47 | 2 | 7p14.3 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 2.05e-05 | 4 | 34 | 2 | 1163 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 5.75e-04 | 19 | 34 | 2 | 50 | |
| GeneFamily | PHD finger proteins | 6.38e-04 | 90 | 34 | 3 | 88 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.17e-03 | 27 | 34 | 2 | 47 | |
| GeneFamily | LIM domain containing | 5.49e-03 | 59 | 34 | 2 | 1218 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.04e-02 | 718 | 34 | 5 | 28 | |
| Coexpression | NABA_MATRISOME | PCSK5 LAMA5 ADAMTS20 SLIT2 FBLN2 BMPER ADAMTS2 SSPOP ADAM21 VWDE ADAM28 WNT3 F12 MEGF10 SLIT1 OTOG | 9.97e-12 | 1008 | 47 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | PCSK5 LAMA5 ADAMTS20 SLIT2 FBLN2 BMPER ADAMTS2 SSPOP ADAM21 VWDE ADAM28 WNT3 F12 MEGF10 SLIT1 OTOG | 1.30e-11 | 1026 | 47 | 16 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.69e-09 | 191 | 47 | 8 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.08e-09 | 196 | 47 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 2.54e-08 | 270 | 47 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.93e-08 | 275 | 47 | 8 | M5884 | |
| Coexpression | NABA_ECM_REGULATORS | 4.14e-06 | 238 | 47 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 4.55e-06 | 242 | 47 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.53e-05 | 738 | 47 | 8 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 5.12e-05 | 751 | 47 | 8 | M5885 | |
| Coexpression | GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR | 1.33e-04 | 55 | 47 | 3 | M39143 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 1.40e-04 | 147 | 47 | 4 | MM414 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 1.57e-04 | 286 | 47 | 5 | M45746 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-08 | 184 | 47 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-08 | 184 | 47 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-08 | 184 | 47 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 182 | 47 | 5 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 182 | 47 | 5 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-06 | 190 | 47 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-06 | 200 | 47 | 5 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-06 | 200 | 47 | 5 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 146 | 47 | 4 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 152 | 47 | 4 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-05 | 162 | 47 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 166 | 47 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 166 | 47 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 166 | 47 | 4 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 168 | 47 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.31e-05 | 173 | 47 | 4 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-05 | 177 | 47 | 4 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 177 | 47 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-05 | 177 | 47 | 4 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 179 | 47 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 179 | 47 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-05 | 180 | 47 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 4.12e-05 | 183 | 47 | 4 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.21e-05 | 184 | 47 | 4 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 186 | 47 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.39e-05 | 186 | 47 | 4 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.39e-05 | 186 | 47 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 186 | 47 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 188 | 47 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 189 | 47 | 4 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-05 | 189 | 47 | 4 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-05 | 189 | 47 | 4 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 191 | 47 | 4 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.87e-05 | 191 | 47 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.87e-05 | 191 | 47 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 191 | 47 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 192 | 47 | 4 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 192 | 47 | 4 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 192 | 47 | 4 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 5.07e-05 | 193 | 47 | 4 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.07e-05 | 193 | 47 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.07e-05 | 193 | 47 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-05 | 193 | 47 | 4 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.07e-05 | 193 | 47 | 4 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.17e-05 | 194 | 47 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | COVID-19_Mild-CD8+_T_naive|COVID-19_Mild / Disease condition and Cell class | 5.17e-05 | 194 | 47 | 4 | 4e42df4f6db456ab914ddfb2a938dfc462f8b6bf | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.17e-05 | 194 | 47 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 5.49e-05 | 197 | 47 | 4 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 198 | 47 | 4 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-05 | 198 | 47 | 4 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.71e-05 | 199 | 47 | 4 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.71e-05 | 199 | 47 | 4 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.71e-05 | 199 | 47 | 4 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.82e-05 | 200 | 47 | 4 | 413ac64bbe95b8c921c5396d8b5f298fec8c4f82 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Control-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.81e-04 | 104 | 47 | 3 | 5f72aa686b0fb83d401621e1b9d9c69e56105570 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.49e-04 | 116 | 47 | 3 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-04 | 130 | 47 | 3 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.81e-04 | 134 | 47 | 3 | 3dd4b5eddc94c1d49ab23b287ee234db3a55331b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.89e-04 | 135 | 47 | 3 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.42e-04 | 141 | 47 | 3 | b2857b73fd754b879b922c7720b5ac3024976822 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-04 | 141 | 47 | 3 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 145 | 47 | 3 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.50e-04 | 152 | 47 | 3 | bffbbdf1047c59e5241c99dc10b36cfe2071aa48 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.60e-04 | 153 | 47 | 3 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-04 | 154 | 47 | 3 | 923f5eb8e9258105dbdbe57a5e7976ef60dae29b | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.71e-04 | 154 | 47 | 3 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-04 | 155 | 47 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.82e-04 | 155 | 47 | 3 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.04e-04 | 157 | 47 | 3 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.27e-04 | 159 | 47 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-04 | 160 | 47 | 3 | 50d4f867d021abcfeb49e6812bcfd5bb57466a31 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-04 | 160 | 47 | 3 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-04 | 160 | 47 | 3 | 0f15f895f11dcabb73df79b26bfc4947f38435a7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-04 | 160 | 47 | 3 | 7d004bfe42707605b3851cb2319126acda4d4802 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 161 | 47 | 3 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 161 | 47 | 3 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 161 | 47 | 3 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 6.50e-04 | 161 | 47 | 3 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 6.50e-04 | 161 | 47 | 3 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 15d5d31a75e26bcd41919a00300c68e9f00f0002 | |
| ToppCell | Club-club-13|World / Class top | 6.61e-04 | 162 | 47 | 3 | 7d18f05a65ac715e62d610df9cc4a26539340dee | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 163 | 47 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-04 | 163 | 47 | 3 | 2dbdcbc4c187aad3db837d191cc78662a75dd0b5 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.85e-04 | 164 | 47 | 3 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 6.98e-04 | 165 | 47 | 3 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.10e-04 | 166 | 47 | 3 | d16af6570806ed2880bd0efb5298932fd2a89cf5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-04 | 167 | 47 | 3 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.35e-04 | 168 | 47 | 3 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 7.35e-04 | 168 | 47 | 3 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.48e-04 | 169 | 47 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.11e-04 | 10 | 47 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Alzheimer disease | 1.16e-04 | 485 | 47 | 6 | MONDO_0004975 | |
| Disease | esophageal adenocarcinoma | 3.74e-04 | 18 | 47 | 2 | EFO_0000478 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.17e-04 | 19 | 47 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 4.63e-04 | 20 | 47 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | CFTR mutation carrier status | 7.28e-04 | 25 | 47 | 2 | EFO_0021794 | |
| Disease | sleep quality | 8.89e-04 | 118 | 47 | 3 | EFO_0005272 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGGCVLSHGHKQLMC | 1341 | P13569 | |
| HPLFVGGMCQNCKNC | 506 | Q9Y6K1 | |
| VIHCHKCGEPCKGEV | 96 | O14639 | |
| PCHHGKGHCLMGTCP | 496 | Q9UKQ2 | |
| MKGICNNKHHCHCGY | 641 | Q9UKJ8 | |
| PGMHCRHGLCVNKET | 536 | P59510 | |
| GTMCAPGKHCFKGHC | 536 | O95450 | |
| SGEMCVPHCADKCVH | 101 | Q96KG7 | |
| HSCHPMSGECACKPG | 376 | Q96KG7 | |
| ECISKPCMNHGLCHN | 876 | Q04721 | |
| CLPCHDKMGVPICGA | 186 | Q7Z4I7 | |
| GKGPCSHMCLINHNR | 1536 | Q9NZR2 | |
| KELPCGHRCKEMCHP | 771 | Q6ZNB6 | |
| GHRCKEMCHPGECPF | 776 | Q6ZNB6 | |
| SICPMGTCHAIPAHC | 791 | Q6ZRS4 | |
| GIKCQMDHTAFPCGC | 256 | Q96S65 | |
| CPQCGQVGCVHAGHK | 131 | P98095 | |
| DEGFCCCEPGHIPHM | 1636 | Q96RV3 | |
| HVAVKGVCKHCPEMC | 1316 | Q92824 | |
| GVCKHCPEMCQDCIH | 1321 | Q92824 | |
| PGCKPCHVKCFHCMG | 1466 | Q92824 | |
| CHVKCFHCMGPAEDQ | 1471 | Q92824 | |
| PCGMHKCQRLCHKGE | 831 | Q12986 | |
| HVIPGHMACSMACGG | 46 | A2A3K4 | |
| CHPQSGQCHCRPGTM | 2081 | O15230 | |
| HTCGHDCCKIGVAQK | 1151 | A2PYH4 | |
| MECKTCIICGQPHHE | 431 | Q8WUB8 | |
| TQPKTDHAHCCVEMG | 361 | Q08828 | |
| VVHCKNPLEHLGMCC | 146 | Q8N8U9 | |
| CHAGKGMVCQEHSCK | 1611 | Q9Y6R7 | |
| GMVCQEHSCKPGQVC | 1616 | Q9Y6R7 | |
| GVHNIGICCCMDPKS | 576 | Q99698 | |
| HTCRCGVPACSHVPM | 201 | Q8N1N5 | |
| CHLCCPDGHMQHAVL | 401 | Q9H7H0 | |
| PSLGHCHCKDGVMSC | 861 | Q6ZRI0 | |
| VRPCKMGLCQHHHSG | 471 | O15403 | |
| DHCSKHSPCQKGGTC | 96 | P00748 | |
| KCICHQCALWGGMHG | 111 | O94972 | |
| TNQTCHPGCHCPSGM | 3116 | A2VEC9 | |
| VPCGHNLFCMECANK | 621 | Q5U5Q3 | |
| NHPHMDCVITGRPCC | 586 | Q96CC6 | |
| PMCSNHGICVKGECH | 631 | Q9UKZ4 | |
| CLPCHDKMGVPICGA | 181 | P48059 | |
| AFCHPPCKNGGHCMR | 1456 | Q8N2E2 | |
| PCKNGGHCMRNNVCV | 1461 | Q8N2E2 | |
| HCPGATIGCDVKTCH | 86 | Q8IWS0 | |
| RTHTGEKPCQCKHCG | 316 | Q15935 | |
| HMHLKCKCHGLSGSC | 201 | P56703 | |
| CISNPCKHGGTCHLK | 961 | O94813 | |
| CHKKVCAHGTCQPSS | 1336 | O94813 | |
| CHTGEKPLHCNKCGM | 446 | Q6ZN19 | |
| MIRHTGNGPHKCKIC | 356 | Q9Y2A4 | |
| TACECNQCGKPLHHK | 221 | Q5JVG2 | |
| NAMVCFHCRKPGHGI | 126 | Q8N567 | |
| CHGHKCVHGQCVPLD | 1381 | O75093 | |
| SHCTGEKTHKCPECG | 296 | Q8NC26 |